Tenvie Therapeutics
The Clinical Development Scientist at Tenvie Therapeutics will design and execute early-phase clinical programs focused on cardiometabolic disease and related indications, integrating nonclinical and translational data to guide dose selection and study endpoints. The role collaborates cross‑functionally with Clinical Operations, Biometrics, Regulatory, and Translational Science to produce high‑quality clinical documents, data analyses, and scientific communications.
Headquarters
South San Francisco, California, United States
Company Size
1-10 employees
Tenvie Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the treatment of neurological and peripheral diseases. The company develops precision-engineered small molecule therapies targeting neuroinflammation and cellular dysfunction, with a CNS-centric approach that produces both fully CNS-penetrant and peripherally restricted assets. Tenvie has active Phase 1 clinical trials underway for candidates including TNV108 and TNV262.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tenvie Therapeutics.
18% below the average for this role
DMPK and Clinical Pharmacology Scientist
GondolaBio Service Co, Inc.
Director, Clinical Scientist
Spyre Therapeutics
DMPK-PD Project Leader
Roche
Principal Scientist, Drug Metabolism and Pharmacokinetics
alnylam
Principal Scientist – Cardiometabolic Diseases/Obesity Research
Amgen
Scientist / Senior Scientist of In Vivo Pharmacology
NewLimit